As of September 2023 Cerus has a market cap of $0.27 Billion. This makes Cerus the world's 6259th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.27 B | -57.84% |
2022 | $0.64 B | -45.24% |
2021 | $1.18 B | 1.63% |
2020 | $1.16 B | 91.12% |
2019 | $0.60 B | -12.24% |
2018 | $0.69 B | 77.65% |
2017 | $0.39 B | -13.22% |
2016 | $0.45 B | -28.13% |
2015 | $0.62 B | 24.83% |
2014 | $0.50 B | 8.25% |
2013 | $0.46 B | 160.74% |
2012 | $0.17 B | 31.98% |
2011 | $0.13 B | 15.68% |
2010 | $0.11 B | 51.27% |
2009 | $76.96 M | 238.33% |
2008 | $22.75 M | -89.15% |
2007 | $0.20 B | 12.72% |
2006 | $0.18 B | -18.42% |
2005 | $0.22 B | 247.89% |
2004 | $65.52 M | -34.58% |
2003 | $0.10 B | -70.79% |
2002 | $0.34 B | -52.37% |
2001 | $0.71 B |
On Sep 21st, 2023 the market cap of Cerus was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Boston Scientific BSX | $79.02 B | 28,845.01% | ๐บ๐ธ USA |
![]() Utah Medical Products UTMD | $0.30 B | 11.49% | ๐บ๐ธ USA |
![]() Haemonetics HAE | $4.56 B | 1,573.41% | ๐บ๐ธ USA |
![]() Eterna Therapeutics ERNA | $11.25 M | -95.88% | ๐บ๐ธ USA |